Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

May 24, 2005

New Study Demonstrates Clinical Efficacy of Telithromycin Superior to Standard First-Line Antibiotic Therapy for Treatment of Mild to Moderate Community-Acquired Pneumonia (CAP)
May 23, 2005

New Data Demonstrate Alvesco® (ciclesonide) Significantly Reduces Oral Corticosteroid Use in Patients with Severe, Persistent Asthma
May 15, 2005

Taxotere® Regimen Demonstrates Significant Survival Benefit In The Treatment Of Advanced Gastric Cancer
May 13, 2005

Sanofi-aventis 2005 first-quarter net sales
May 10, 2005

Rescheduling of the pre-trial order date in the United States Plavix® litigation
May 10, 2005

New Eloxatin® and Taxotere® research to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO)
Apr 15, 2005

Sanofi-aventis affirms its commitment to Access to Medicines in the "Southern countries", with a policy of tiered drug prices geared to populations incomes
Apr 11, 2005

FDA issues approvable letter for AMBIEN CR™ (zolpidem tartrate extended release) C IV for the treatment of Insomnia
Apr 7, 2005

Sanofi-aventis Statement
Apr 1, 2005

Sanofi-aventis concludes €10 billion in medium-term credit agreements with its banks to refinance the Aventis acquisition financing entered into in April 2004

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.